266 related articles for article (PubMed ID: 19919035)
1. Novel organic proteasome inhibitors identified by virtual and in vitro screening.
Basse N; Montes M; Maréchal X; Qin L; Bouvier-Durand M; Genin E; Vidal J; Villoutreix BO; Reboud-Ravaux M
J Med Chem; 2010 Jan; 53(1):509-13. PubMed ID: 19919035
[TBL] [Abstract][Full Text] [Related]
2. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
[TBL] [Abstract][Full Text] [Related]
3. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Shallal HM; Russu WA
Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632
[TBL] [Abstract][Full Text] [Related]
4. Retro hydrazino-azapeptoids as peptidomimetics of proteasome inhibitors.
Aubin S; Martin B; Delcros JG; Arlot-Bonnemains Y; Baudy-Floc'h M
J Med Chem; 2005 Jan; 48(1):330-4. PubMed ID: 15634028
[TBL] [Abstract][Full Text] [Related]
5. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Fused cyclohexyl sulfones as gamma-secretase inhibitors.
Shaw D; Best J; Dinnell K; Nadin A; Shearman M; Pattison C; Peachey J; Reilly M; Williams B; Wrigley J; Harrison T
Bioorg Med Chem Lett; 2006 Jun; 16(11):3073-7. PubMed ID: 16617016
[TBL] [Abstract][Full Text] [Related]
7. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of naphthoquinone derivatives as antiproliferative agents and 20S proteasome inhibitors.
Xu K; Xiao Z; Tang YB; Huang L; Chen CH; Ohkoshi E; Lee KH
Bioorg Med Chem Lett; 2012 Apr; 22(8):2772-4. PubMed ID: 22437113
[TBL] [Abstract][Full Text] [Related]
9. New aldehyde and vinylsulfone proteasome inhibitors for targeted melanoma therapy.
Vivier M; Rapp M; Galmier MJ; Jarrousse AS; Miot-Noirault E; Leal F; Weber V; Métin J; Sauzière J; Chezal JM; Madelmont JC
Eur J Med Chem; 2011 Nov; 46(11):5705-10. PubMed ID: 21924528
[TBL] [Abstract][Full Text] [Related]
10. Isolation, synthesis, and anti-tumor activities of a novel class of podocarpic diterpenes.
Xiong Y; Wang K; Pan Y; Sun H; Tu J
Bioorg Med Chem Lett; 2006 Feb; 16(4):786-9. PubMed ID: 16309905
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anti-inflammatory activity, and in vitro antitumor effect of a novel class of cyclooxygenase inhibitors: 4-(aryloyl)phenyl methyl sulfones.
Harrak Y; Casula G; Basset J; Rosell G; Plescia S; Raffa D; Cusimano MG; Pouplana R; Pujol MD
J Med Chem; 2010 Sep; 53(18):6560-71. PubMed ID: 20804197
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.
Dorsey BD; Iqbal M; Chatterjee S; Menta E; Bernardini R; Bernareggi A; Cassarà PG; D'Arasmo G; Ferretti E; De Munari S; Oliva A; Pezzoni G; Allievi C; Strepponi I; Ruggeri B; Ator MA; Williams M; Mallamo JP
J Med Chem; 2008 Feb; 51(4):1068-72. PubMed ID: 18247547
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
14. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological characterization of argyrin F.
Bülow L; Nickeleit I; Girbig AK; Brodmann T; Rentsch A; Eggert U; Sasse F; Steinmetz H; Frank R; Carlomagno T; Malek NP; Kalesse M
ChemMedChem; 2010 Jun; 5(6):832-6. PubMed ID: 20358576
[No Abstract] [Full Text] [Related]
16. Proteasome inhibitors for cancer therapy.
Iqbal M; Messina McLaughlin PA; Dunn D; Mallya S; Husten J; Ator MA; Chatterjee S
Bioorg Med Chem; 2012 Apr; 20(7):2362-8. PubMed ID: 22377673
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach.
Gundla R; Kazemi R; Sanam R; Muttineni R; Sarma JA; Dayam R; Neamati N
J Med Chem; 2008 Jun; 51(12):3367-77. PubMed ID: 18500794
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition by peptide-semicarbazones.
Leban J; Blisse M; Krauss B; Rath S; Baumgartner R; Seifert MH
Bioorg Med Chem; 2008 Apr; 16(8):4579-88. PubMed ID: 18313310
[TBL] [Abstract][Full Text] [Related]
19. Novel fluorinated pseudopeptides as proteasome inhibitors.
Formicola L; Maréchal X; Basse N; Bouvier-Durand M; Bonnet-Delpon D; Milcent T; Reboud-Ravaux M; Ongeri S
Bioorg Med Chem Lett; 2009 Jan; 19(1):83-6. PubMed ID: 19041239
[TBL] [Abstract][Full Text] [Related]
20. Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach.
Oyarzabal J; Zarich N; Albarran MI; Palacios I; Urbano-Cuadrado M; Mateos G; Reymundo I; Rabal O; Salgado A; Corrionero A; Fominaya J; Pastor J; Bischoff JR
J Med Chem; 2010 Sep; 53(18):6618-28. PubMed ID: 20722422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]